Sign Up to like & get
recommendations!
0
Published in 2019 at "Tumor Biology"
DOI: 10.1158/1538-7445.am2019-1194
Abstract: INTRODUCTION: Hematopoietic stem and progenitor cell (HSPC) transfer during adoptive T cell immunotherapy (ACT) prolongs median survival and generates 30% long-term cures for malignant brain tumors. We recently demonstrated during ACT that intratumoral HSPCs differentiate…
read more here.
Keywords:
adoptive cellular;
naive hspcs;
cell;
hspc ... See more keywords